⭐️ Presented by the Center for the Advancement of Multicultural Perspectives on Science (DEI | OAD)

Alan Lombard

Assistant Professor, Biochemistry and Molecular Medicine and Urology

Characterization of PARP Inhibitor Response in Prostate Tumor Cells Reveals Drug Tolerant Persistent Phenotype

Abstract: PARP inhibition is significantly improving how we manage advanced prostate cancer. Despite this progress, resistance and progression remain inevitable. Our findings reveal that response to PARP inhibition may be characterized as drug tolerant persistence, which could be a path toward development of treatment insensitivity. We seek to understand and target the drug tolerant persistent phenotype to improve treatment efficacy and improve patient outcomes.

Check out our other CAMPOS speakers lined up for the 2024-2025 year on our CAMPOS Colloquium page!